ALAB

Astera Labs
D

ALAB

Arincen89/100B
221.790
USD
-6.10
(-2.68%)
Post Trading·216.770USD-5.020(-2.26%)
Last updated: · Delayed 15 min

Astera Labs financials

Yes. Astera Labs earned 461.32M USD of net income over the last twelve months, 29.6% of its revenue. It made a profit in 1 of its 4 fiscal years since 2022. Its last loss was in fiscal year 2024.

Revenue (TTM)
1.56B USD
Net income (TTM)
461.32M USD
Free cash flow (TTM)
344.69M USD
Cash and short-term investments
1.38B USD
Total debt
0.00 USD
Shareholders' equity
2.00B USD

Cash, debt and equity as of 30 Sept 2026.

Astera Labs earnings

Next earnings · Q4 FY2026
EPS estimate
1.64 USD
Revenue estimate
743.62M USD
Last quarter · Q3 FY2026
EPS1.32Beat +10.9%Revenue584.90MBeat +6.2%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growth
Q3 FY20271.84——+39.32%882.87M——+50.94%
Q2 FY20271.74——+117.05%822.96M——+109.72%
Q1 FY20271.67——+174.06%779.73M——+152.86%
Q4 FY20261.64——+182.76%743.62M——+174.82%
Q3 FY20261.191.32+10.92%+169.39%550.78M584.90M+6.19%+153.67%
Q2 FY20260.690.80+15.77%+81.82%360.85M392.40M+8.74%+104.45%
Q1 FY20260.540.61+13.59%+84.85%292.19M308.36M+5.53%+93.40%
Q4 FY20250.520.58+12.40%+56.76%249.54M270.58M+8.43%+91.77%
Q3 FY20250.390.49+25.67%+113.04%206.46M230.58M+11.68%+103.89%
Q2 FY20250.320.44+35.76%+238.46%172.49M191.93M+11.27%+149.74%

Astera Labs growth and profitability

Full income statement
Revenue (TTM)
1.56B USD
Net income (TTM)
461.32M USD
Gross margin
73.89%
Operating margin
25.52%
Net margin
29.64%

Revenue / Net income

Revenue Net income Net margin
PeriodRevenueGrowthNet incomeGrowthGross marginOperating marginNet marginEBITDAGrowth
FY2025852.53M+115.13%219.13M—75.69%20.34%25.70%224.98M—
FY2024396.29M+242.24%-83.42M—76.38%-29.29%-21.05%-78.62M—
FY2023115.79M+44.97%-26.26M—68.94%-25.47%-22.68%-21.17M—
FY202279.87M—-58.35M—73.47%-75.36%-73.05%-56.77M—

How Astera Labs makes its money

Reportable852.53M 100.0%
Revenue852.53M 100.0%
Cost of revenue207.26M 24.3%
Gross profit645.26M 75.7%
Research and development304.00M 35.7%
Selling and administration167.84M 19.7%
Operating income173.42M 20.3%
Net income219.13M 25.7%

FY2025, in USD. Each band is as wide as its money; the percentage is its share of revenue.

Astera Labs revenue breakdown

By product

FY2025
100.0%Reportable
SegmentRevenueShare of revenueChange on the year
Reportable852.53M100.0%—

By region

FY2025
Singapore: 32.5%China: 30.1%Taiwan: 29.0%Non-US: 5.2%United States: 3.2%32.5%Singapore30.1%China29.0%Taiwan5.2%Non-US3.2%United States
RegionRevenueShare of revenueChange on the year
Singapore276.99M32.5%—
China256.28M30.1%+252.6%
Taiwan247.45M29.0%-8.3%
Non-US44.38M5.2%+4.7%
United States27.43M3.2%+142.8%

Operating and free cash flow

Full cash flow statement
Operating cash flow Free cash flow
Fiscal yearOperating cash flowFree cash flow
FY2025319.31M281.76M
FY2024136.68M102.43M
FY2023-12.72M-15.48M
FY2022-35.90M-39.77M

Astera Labs financial health

Full balance sheet
Cash and short-term investments
1.38B USD
Total debt
0.00 USD
Net cash
1.38B USD
Free cash flow (TTM)
344.69M USD
Current ratio
8.03
Debt to equity
0.00
Piotroski score
5 / 9
Altman Z-score
77.48

Cash, debt and free cash flow

Cash and short-term investments Total debt Free cash flow
Fiscal yearCash and short-term investmentsTotal debtFree cash flow
FY20251.19B35.15M281.76M
FY2024914.30M1.29M102.43M
FY2023149.31M2.93M-15.48M
FY2022163.14M1.60M-39.77M

Assets, liabilities and equity

Total assets Total liabilities Shareholders' equity
Fiscal yearTotal assetsTotal liabilitiesShareholders' equity
FY20251.53B168.19M1.36B
FY20241.05B89.71M964.80M
FY2023196.29M38.87M157.43M
FY2022211.73M297.02M-85.29M

Astera Labs valuation

Price to earnings ratio (TTM)
82.76
Forward P/E (FY2026)
51.70
Price to sales (TTM)
24.91
Price to book
19.39
EV / EBITDA (TTM)
84.07

Capital structure

Market capitalization
38.76B USD
+
Total debt
0.00 USD
−
Cash and short-term investments
1.38B USD
=
Enterprise value
37.39B USD

Valuation over time

P/EForward P/EForward P/E · EstimateEstimate
Fiscal yearP/EForward P/EP/SP/BEV/EBITDA
FY2028 (est.)24.71————
FY2027 (est.)31.4424.71———
FY2026 (est.)51.7031.44———
Now (TTM)82.7633.1124.9119.3984.07
FY2025126.0338.7732.4720.30122.46
FY2024-206.9574.4143.8718.02-220.13
FY2023-364.88—81.6960.09-444.92
FY2022-137.84—101.31-94.87-141.22

Astera Labs against its own history

Each figure in the latest fiscal year against the same figure from FY2021 to FY2025: the range, its median (the line) and the latest (the dot, green on the good side of the median). The P/E is today's against its daily readings of five years.

Its peers: Microchip Technology, Teradyne, Microchip Technology, ON Semiconductor, Qnity Electronics, and GLOBALFOUNDRIES, the US Semiconductors companies closest to it in size, each in its own latest fiscal year: their median (the line) and its rank among them, first being the best.

  • Gross marginAbove its median75.7%
    68.9%76.4%
    Against its peers: 1 of 6Peers' median 41.8%
  • Operating marginHighest in 5 years20.3%
    -75.4%20.3%
    Against its peers: 3 of 6Peers' median 11.7%
  • Net marginHighest in 5 years25.7%
    -73.0%25.7%
    Against its peers: 1 of 6Peers' median 13.0%
  • Return on equityHighest in 5 years16.1%
    -16.7%16.1%
    Against its peers: 2 of 6Peers' median 7.4%
  • Free cash flow marginHighest in 5 years33.1%
    -49.8%33.1%
    Against its peers: 1 of 6Peers' median 18.5%
  • Revenue growthAt its median115.1%
    45.0%242.2%
    Against its peers: 1 of 6Peers' median 7.1%
  • Current ratioAbove its median10.24
    5.1411.71
    Against its peers: 1 of 6Peers' median 2.09

Peers: US companies of the same industry (of its sector when the industry has too few) from a tenth to ten times its market value, the six closest in size. Updated weekly.

Astera Labs ownership

Institutions
75.30%
Institutional holders
1,070 (+306)
Free float
82.28%

Who owns the shares

Institutions 75.3% Others 24.7%
As of 30 Jun 2026

Shares free to trade

Free float 143.81M shares ·82.3% Closely held 30.97M shares ·17.7%

Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.

Insider trading

QuarterPurchasesSalesShares acquiredShares disposed of
Q4 202603208.0012.50K
Q3 202601761.45K591.56K
Q2 20260204280.09K2.38M
Q1 202605495.66K394.29K

Shares outstanding

Basic shares Diluted shares Change in diluted shares
Fiscal yearBasic sharesDiluted sharesChange in diluted shares
FY2025166.41M179.55M+36.79%
FY2024131.26M131.26M-13.93%
FY2023152.50M152.50M+16.90%
FY2022130.45M130.45M—

Common questions about Astera Labs's financials

Source: Financial Modeling Prep